Filing Details
- Accession Number:
- 0001209191-19-049117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-11 12:35:25
- Reporting Period:
- 2019-09-11
- Accepted Time:
- 2019-09-11 12:35:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1248093 | D Emil Kakkis | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-11 | 5,000 | $43.63 | 472,479 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,559,741 | Indirect | By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 |
Billionaire Hedge Funds
